Skip to main content

Published locations for ATLAS: High-risk RCC patients might benefit from adjuvant axitinib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ATLAS: High-risk RCC patients might benefit from adjuvant axitinib

User login

  • Reset your password
  • /content/atlas-high-risk-rcc-patients-might-benefit-adjuvant-axitinib
  • /oncologypractice/article/178626/renal-cell-carcinoma/atlas-high-risk-rcc-patients-might-benefit
  • /hematology-oncology/article/178626/renal-cell-carcinoma/atlas-high-risk-rcc-patients-might-benefit